CClinicalTrials.gg
CompletedNCT04732325Updated Mar 27, 2026Results posted

Sensory Testing of Multiple Forms of Spinal Cord Stimulation for Pain

An interventional study of Spinal cord stimulation in Chronic Pain, Failed Back Surgery Syndrome and Complex Regional Pain Syndromes, sponsored by University of Michigan. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-27.

Sponsored by University of Michigan · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Doctors sometimes treat chronic pain with devices that send mild electrical currents into the spinal cord. This type of treatment is referred to as neurostimulation. A common form of neurostimulation therapy is spinal cord stimulation (SCS). In this study, how SCS affects pain processing and relieves pain will be studied. Multiple forms of SCS will be examined in chronic pain patients who are receiving SCS from their own doctors as part of their standard of care. During the study, participants will be asked to complete a variety of evaluations at certain time points.

02

Conditions studied

  • Chronic Pain
  • Failed Back Surgery Syndrome
  • Complex Regional Pain Syndromes
  • Neuropathic Pain

Keywords

  • Spinal cord stimulation
03

In context

Chronic Pain

2,930 studies on the registry are indexed under Chronic Pain; 701 are open to participants now.

This study's enrollment of 34 is below the median of 60 across 2,161 interventional studies indexed under Chronic Pain.

Browse Chronic Pain studies →

Lead sponsor

University of Michigan is the lead sponsor of 1,475 studies on the registry; 196 are open to participants now.

Of its 162 completed or terminated interventional studies of FDA-regulated products, 128 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Chronic intractable pain of the trunk and/or limbs
  • Undergoing SCS as part of standard clinical care for chronic pain management
  • Candidates will have been implanted with a commercial SCS device
  • Candidates who are 18 years or older and can speak, read, and understand English
  • Able to understand study procedures and to comply with them for the entire length of the study
  • Must be willing to participate in COVID-19 symptom screening and answer questions about COVID-19 diagnosis 1-3 days before a scheduled visit
  • Must be willing to wear a face-covering during all study visits

Exclusion criteria

Exclusion criteria:

  • Subjects who are pregnant or nursing
  • Subjects with current, habitual, or previous use within the last 12 months of artificial nails, nail enhancements, or nail extensions that cover any portion of either thumbnail
  • Subjects who are unable or unwilling to cooperate with clinical testing
  • Subjects having any impairment, activity or situation that in the judgment of study personnel would prevent satisfactory completion of the study protocol
  • Inability or unwillingness of individual or legal guardian/representative to give written informed consent
  • Subjects who currently have or tested positive in the last 14 days for COVID-19, or are symptomatic for COVID-19
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
34 participants (actual)

Study arms

  • Experimental
    Burst / kHz / Sham / Tonic

    Participants will be randomized to one of six treatment arms. Participants will receive burst, kHz, tonic, and sham spinal cord stimulation (SCS). Each treatment will be applied for a duration of seven days. Participants will be blinded during programming.

    Device: Spinal cord stimulation

  • Experimental
    Burst / Sham / kHz / Tonic

    Participants will be randomized to one of six treatment arms. Participants will receive burst, kHz, tonic, and sham spinal cord stimulation (SCS). Each treatment will be applied for a duration of seven days. Participants will be blinded during programming.

    Device: Spinal cord stimulation

  • Experimental
    kHz / Sham / Burst / Tonic

    Participants will be randomized to one of six treatment arms. Participants will receive burst, kHz, tonic, and sham spinal cord stimulation (SCS). Each treatment will be applied for a duration of seven days. Participants will be blinded during programming.

    Device: Spinal cord stimulation

  • Experimental
    kHz / Burst / Sham / Tonic

    Participants will be randomized to one of six treatment arms. Participants will receive burst, kHz, tonic, and sham spinal cord stimulation (SCS). Each treatment will be applied for a duration of seven days. Participants will be blinded during programming.

    Device: Spinal cord stimulation

  • Experimental
    Sham / Burst / kHz / Tonic

    Participants will be randomized to one of six treatment arms. Participants will receive burst, kHz, tonic, and sham spinal cord stimulation (SCS). Each treatment will be applied for a duration of seven days. Participants will be blinded during programming.

    Device: Spinal cord stimulation

  • Experimental
    Sham / kHz / Burst / Tonic

    Participants will be randomized to one of six treatment arms. Participants will receive burst, kHz, tonic, and sham spinal cord stimulation (SCS). Each treatment will be applied for a duration of seven days. Participants will be blinded during programming.

    Device: Spinal cord stimulation

Interventions

  • DeviceSpinal cord stimulation

    The spinal cord stimulation (SCS) system will be programmed to deliver, according to the randomization status of the participant, burst, kHz, tonic, and sham stimulation.

06

What researchers measure

Primary outcomes

  1. Spinal Cord Stimulation (SCS)-Induced Changes in Temporal Summation (TS)

    TS refers to an increased perception of pain in response to sequential stimuli of equal physical strength. At the end of each treatment period, TS scores were calculated by subtracting the average pain rating of the single-stimulus trials from the average pain rating of the ten-stimuli trials. If the difference is a positive number, the researchers will conclude that there was pain summation, where larger numbers will indicate increased pain summation or TS. If the difference is zero or a negative number, the researchers will conclude that there was no pain summation or TS.

    Time frame: Up to 30 days

Other outcomes

  1. SCS-induced Changes in Temporal Summation (TS) - 50Hz (Tonic)-SCS to Sham-SCS

    Temporal summation (TS) refers to an increased perception of pain in response to sequential stimuli of equal physical strength. At the end of each treatment period, TS scores were calculated by subtracting the average pain rating of the single-stimulus trials from the average pain rating of the ten-stimulus trials. TS scores range from a minimum of -100 to a maximum of 100. If the difference was a positive number, then pain summation was present, where larger numbers indicate increased pain summation or TS. If the difference was zero or a negative number, then no pain summation or TS was present. Results show in-participant comparisons calculated as the Tonic-SCS score minus the Sham-SCS score for each individual across the entire study, regardless of sequence. Negative values indicate improvement (i.e., reduced pain summation or TS with Tonic-SCS relative to Sham-SCS) and positive values indicate worsening (i.e., increased pain summation or TS with Tonic-SCS relative to Sham-SCS).

    Time frame: Up to 30 days

  2. SCS-induced Changes in Temporal Summation (TS) - 1kHz-SCS to Sham-SCS

    Temporal summation (TS) refers to an increased perception of pain in response to sequential stimuli of equal physical strength. At the end of each treatment period, TS scores were calculated by subtracting the average pain rating of the single-stimulus trials from the average pain rating of the ten-stimulus trials. The TS scores range from a minimum of -100 to a maximum of 100. If the difference was a positive number, then pain summation was present, where larger numbers indicate increased pain summation or TS. If the difference was zero or a negative number, then no pain summation or TS was present. Results show in-participant comparisons calculated as the kHz-SCS score minus the Sham-SCS score for each individual across the entire study, regardless of sequence. Negative values indicate improvement (i.e., reduced pain summation or TS with kHz-SCS relative to Sham-SCS) and positive values indicate worsening (i.e., increased pain summation or TS with kHz-SCS relative to Sham-SCS).

    Time frame: Up to 30 days

  3. Spinal Cord Stimulation (SCS)-Induced Changes in Temporal Summation (TS) - Burst-SCS to Sham-SCS

    Temporal summation (TS) refers to an increased perception of pain in response to sequential stimuli of equal physical strength. At the end of each treatment period, TS scores were calculated by subtracting the average pain rating of the single-stimulus trials from the average pain rating of the ten-stimulus trials. TS scores range from a minimum of -100 to a maximum of 100. If the difference was a positive number, then pain summation was present, where larger numbers indicate increased pain summation or TS. If the difference was zero or a negative number, then no pain summation or TS was present. Results show in-participant comparisons calculated as the Burst-SCS score minus the Sham-SCS score for each individual across the entire study, regardless of sequence. Negative values indicate improvement (i.e., reduced pain summation or TS with Burst-SCS relative to Sham-SCS) and positive values indicate worsening (i.e., increased pain summation or TS with Burst-SCS relative to Sham-SCS).

    Time frame: Up to 30 days

07

Results

Posted Mar 27, 2026

Participant flow

Recruitment period was between October 2021 - May 2024.

Participant flow — Overall Study
MilestoneBurst / 1kHz / Sham / 50Hz (Tonic)Burst / Sham / 1kHz / 50Hz (Tonic)1kHz / Sham / Burst / 50Hz (Tonic)1kHz / Burst / Sham / 50Hz (Tonic)Sham / Burst / 1kHz / 50Hz (Tonic)Sham / 1kHz / Burst / 50Hz (Tonic)
Started445444
Double-blind treatment period 1445444
Double-blind treatment period 2345444
Double-blind treatment period 3345444
Double-blind treatment period 4345444
Completed345444
Not completed100000
Withdrew: Withdrawal by subject100000

Outcome measures

PrimarySpinal Cord Stimulation (SCS)-Induced Changes in Temporal Summation (TS)

TS refers to an increased perception of pain in response to sequential stimuli of equal physical strength. At the end of each treatment period, TS scores were calculated by subtracting the average pain rating of the single-stimulus trials from the average pain rating of the ten-stimuli trials. If the difference is a positive number, the researchers will conclude that there was pain summation, where larger numbers will indicate increased pain summation or TS. If the difference is zero or a negative number, the researchers will conclude that there was no pain summation or TS.

Time frame:
Up to 30 days
Reported as:
Median · score on a scale
Spinal Cord Stimulation (SCS)-Induced Changes in Temporal Summation (TS)
score on a scale1kHzBurst50Hz (Tonic)Sham
TS256 - Pain Site3.67 (0.75 to 9.50)3.33 (1.33 to 5.50)3.67 (0.00 to 10.9)3.33 (1.33 to 14.3)
TS512 - Pain Site8.33 (2.17 to 20.3)5.67 (1.33 to 10.0)8.33 (2.00 to 12.3)7.67 (3.33 to 17.7)
TS256 - Control Site1.67 (0.00 to 11.7)3.50 (0.00 to 8.75)1.17 (0.00 to 12.0)1.50 (0.00 to 16.2)
TS512 - Control Site3.50 (0.67 to 23.7)4.67 (0.08 to 13.0)1.50 (0.00 to 12.4)3.17 (0.25 to 16.2)
Statistical analysis
  • 1kHz vs Burst vs 50Hz (Tonic) vs Sham · Mixed Models Analysis · p = 0.2375
  • 1kHz vs Burst vs 50Hz (Tonic) vs Sham · Mixed Models Analysis · p = 0.2899
  • 1kHz vs Burst vs 50Hz (Tonic) vs Sham · Mixed Models Analysis · p = 0.7472
  • 1kHz vs Burst vs 50Hz (Tonic) vs Sham · Mixed Models Analysis · p = 0.5129
  • 1kHz vs Burst vs 50Hz (Tonic) vs Sham · Mixed Models Analysis · p = 0.3128
  • 1kHz vs Burst vs 50Hz (Tonic) vs Sham · Mixed Models Analysis · p = 0.0058
  • 1kHz vs Burst vs 50Hz (Tonic) vs Sham · Mixed Models Analysis · p = 0.805
  • 1kHz vs Burst vs 50Hz (Tonic) vs Sham · Mixed Models Analysis · p = 0.740
  • 1kHz vs Burst vs 50Hz (Tonic) vs Sham · Mixed Models Analysis · p = 0.1587
  • 1kHz vs Burst vs 50Hz (Tonic) vs Sham · Mixed Models Analysis · p = 0.6179
  • 1kHz vs Burst vs 50Hz (Tonic) vs Sham · Mixed Models Analysis · p = 0.9244
  • 1kHz vs Burst vs 50Hz (Tonic) vs Sham · Mixed Models Analysis · p = 0.5671
  • 1kHz vs Burst vs 50Hz (Tonic) vs Sham · Mixed Models Analysis · p = 0.3619
  • 1kHz vs Burst vs 50Hz (Tonic) vs Sham · Mixed Models Analysis · p = 0.1199
  • 1kHz vs Burst vs 50Hz (Tonic) vs Sham · Mixed Models Analysis · p = 0.912
  • 1kHz vs Burst vs 50Hz (Tonic) vs Sham · Mixed Models Analysis · p = 0.819
Other pre-specifiedSCS-induced Changes in Temporal Summation (TS) - 50Hz (Tonic)-SCS to Sham-SCS

Temporal summation (TS) refers to an increased perception of pain in response to sequential stimuli of equal physical strength. At the end of each treatment period, TS scores were calculated by subtracting the average pain rating of the single-stimulus trials from the average pain rating of the ten-stimulus trials. TS scores range from a minimum of -100 to a maximum of 100. If the difference was a positive number, then pain summation was present, where larger numbers indicate increased pain summation or TS. If the difference was zero or a negative number, then no pain summation or TS was present. Results show in-participant comparisons calculated as the Tonic-SCS score minus the Sham-SCS score for each individual across the entire study, regardless of sequence. Negative values indicate improvement (i.e., reduced pain summation or TS with Tonic-SCS relative to Sham-SCS) and positive values indicate worsening (i.e., increased pain summation or TS with Tonic-SCS relative to Sham-SCS).

Time frame:
Up to 30 days
Reported as:
Least squares mean · score on a scale
SCS-induced Changes in Temporal Summation (TS) - 50Hz (Tonic)-SCS to Sham-SCS
score on a scaleParticipants Who Received Tonic-SCS and Sham-SCS
Temporal summation with 256mN pressure at primary pain (affected) site0.283 (-5.98 to 6.55)
Temporal summation with 512mN pressure at primary pain (affected) site-2.35 (-8.92 to 4.23)
Temporal summation with 256mN pressure at control (unaffected) site0.758 (-3.36 to 4.88)
Temporal summation with 512mN pressure at control (unaffected) site1.318 (-4.29 to 6.92)
Statistical analysis
  • Participants Who Received Tonic-SCS and Sham-SCS · Mixed Models Analysis · p = 0.6050 (P value was adjusted with Dunnett's method.) · Mean difference (final values): -4.21 · 95% CI -14.29 to 5.86
  • Participants Who Received Tonic-SCS and Sham-SCS · Mixed Models Analysis · p = 0.1225 (P value was adjusted with Dunnett's method.) · Mean difference (final values): -8.68 · 95% CI -19.10 to 1.73
  • Participants Who Received Tonic-SCS and Sham-SCS · Mixed Models Analysis · p = 0.8881 (P value was adjusted with Dunnett's method.) · Mean difference (final values): -1.41 · 95% CI -8.04 to 5.21
  • Participants Who Received Tonic-SCS and Sham-SCS · Mixed Models Analysis · p = 0.6374 (P value was adjusted with Dunnett's method.) · Mean difference (final values): -3.58 · 95% CI -12.59 to 5.43
  • Participants Who Received Tonic-SCS and Sham-SCS · Mixed Models Analysis · p = 0.2920 (P value was adjusted with Dunnett's method.) · Mean difference (final values): 4.78 · 95% CI -2.68 to 12.24
  • Participants Who Received Tonic-SCS and Sham-SCS · Mixed Models Analysis · p = 0.4842 (P value was adjusted with Dunnett's method.) · Mean difference (final values): 3.99 · 95% CI -4.04 to 12.01
  • Participants Who Received Tonic-SCS and Sham-SCS · Mixed Models Analysis · p = 0.3454 (P value was adjusted with Dunnett's method.) · Mean difference (final values): 2.93 · 95% CI -1.98 to 7.84
  • Participants Who Received Tonic-SCS and Sham-SCS · Mixed Models Analysis · p = 0.0735 (P value was adjusted with Dunnett's method.) · Mean difference (final values): 6.22 · 95% CI -0.46 to 12.89
Other pre-specifiedSCS-induced Changes in Temporal Summation (TS) - 1kHz-SCS to Sham-SCS

Temporal summation (TS) refers to an increased perception of pain in response to sequential stimuli of equal physical strength. At the end of each treatment period, TS scores were calculated by subtracting the average pain rating of the single-stimulus trials from the average pain rating of the ten-stimulus trials. The TS scores range from a minimum of -100 to a maximum of 100. If the difference was a positive number, then pain summation was present, where larger numbers indicate increased pain summation or TS. If the difference was zero or a negative number, then no pain summation or TS was present. Results show in-participant comparisons calculated as the kHz-SCS score minus the Sham-SCS score for each individual across the entire study, regardless of sequence. Negative values indicate improvement (i.e., reduced pain summation or TS with kHz-SCS relative to Sham-SCS) and positive values indicate worsening (i.e., increased pain summation or TS with kHz-SCS relative to Sham-SCS).

Time frame:
Up to 30 days
Reported as:
Least squares mean · score on a scale
SCS-induced Changes in Temporal Summation (TS) - 1kHz-SCS to Sham-SCS
score on a scaleParticipants Who Received kHz-SCS and Sham-SCS
Temporal summation with 256mN pressure at primary pain (affected) site-4.432 (-10.59 to 1.72)
Temporal summation with 512mN pressure at primary pain (affected) site-3.90 (-10.37 to 2.58)
Temporal summation with 256mN pressure at control (unaffected) site-2.737 (-6.78 to 1.31)
Temporal summation with 512mN pressure at control (unaffected) site-0.917 (-6.42 to 4.59)
Statistical analysis
  • Participants Who Received kHz-SCS and Sham-SCS · Mixed Models Analysis · p = 0.1244 (P value was adjusted with Dunnett's method.) · Mean difference (final values): -8.00 · 95% CI -17.63 to 1.63
  • Participants Who Received kHz-SCS and Sham-SCS · Mixed Models Analysis · p = 0.0065 (P value was adjusted with Dunnett's method.) · Mean difference (final values): -13.17 · 95% CI -23.13 to -3.21
  • Participants Who Received kHz-SCS and Sham-SCS · Mixed Models Analysis · p = 0.3025 (P value was adjusted with Dunnett's method.) · Mean difference (final values): -4.00 · 95% CI -10.33 to 2.33
  • Participants Who Received kHz-SCS and Sham-SCS · Mixed Models Analysis · p = 0.4975 (P value was adjusted with Dunnett's method.) · Mean difference (final values): -4.21 · 95% CI -12.82 to 4.41
  • Participants Who Received kHz-SCS and Sham-SCS · Mixed Models Analysis · p = 0.9697 (P value was adjusted with Dunnett's method.) · Mean difference (final values): -0.87 · 95% CI -8.53 to 6.80
  • Participants Who Received kHz-SCS and Sham-SCS · Mixed Models Analysis · p = 0.2805 (P value was adjusted with Dunnett's method.) · Mean difference (final values): 5.38 · 95% CI -2.89 to 13.64P value was adjusted with Dunnett's method.
  • Participants Who Received kHz-SCS and Sham-SCS · Mixed Models Analysis · p = 0.7921 (P value was adjusted with Dunnett's method.) · Mean difference (final values): -1.47 · 95% CI -6.52 to 3.57
  • Participants Who Received kHz-SCS and Sham-SCS · Mixed Models Analysis · p = 0.7156 (P value was adjusted with Dunnett's method.) · Mean difference (final values): 2.37 · 95% CI -4.49 to 9.24
Other pre-specifiedSpinal Cord Stimulation (SCS)-Induced Changes in Temporal Summation (TS) - Burst-SCS to Sham-SCS

Temporal summation (TS) refers to an increased perception of pain in response to sequential stimuli of equal physical strength. At the end of each treatment period, TS scores were calculated by subtracting the average pain rating of the single-stimulus trials from the average pain rating of the ten-stimulus trials. TS scores range from a minimum of -100 to a maximum of 100. If the difference was a positive number, then pain summation was present, where larger numbers indicate increased pain summation or TS. If the difference was zero or a negative number, then no pain summation or TS was present. Results show in-participant comparisons calculated as the Burst-SCS score minus the Sham-SCS score for each individual across the entire study, regardless of sequence. Negative values indicate improvement (i.e., reduced pain summation or TS with Burst-SCS relative to Sham-SCS) and positive values indicate worsening (i.e., increased pain summation or TS with Burst-SCS relative to Sham-SCS).

Time frame:
Up to 30 days
Reported as:
Least squares mean · score on a scale
Spinal Cord Stimulation (SCS)-Induced Changes in Temporal Summation (TS) - Burst-SCS to Sham-SCS
score on a scaleParticipants Who Received Burst-SCS and Sham-SCS
Temporal summation with 256mN pressure at primary pain (affected) site-2.304 (-8.71 to 4.10)
Temporal summation with 512mN pressure at primary pain (affected) site-5.03 (-11.76 to 1.71)
Temporal summation with 256mN pressure at control (unaffected) site0.621 (-3.59 to 4.83)
Temporal summation with 512mN pressure at control (unaffected) site-1.780 (-7.51 to 3.95)
Statistical analysis
  • Participants Who Received Burst-SCS and Sham-SCS · Mixed Models Analysis · p = 0.3785 (P value was adjusted with Dunnett's method.) · Mean difference (final values): -5.76 · 95% CI -15.83 to 4.31
  • Participants Who Received Burst-SCS and Sham-SCS · Mixed Models Analysis · p = 0.0132 (P value was adjusted with Dunnett's method.) · Mean difference (final values): -12.67 · 95% CI -23.08 to -2.25
  • Participants Who Received Burst-SCS and Sham-SCS · Mixed Models Analysis · p = 0.7098 (P value was adjusted with Dunnett's method.) · Mean difference (final values): -2.32 · 95% CI -8.94 to 4.31
  • Participants Who Received Burst-SCS and Sham-SCS · Mixed Models Analysis · p = 0.1907 (P value was adjusted with Dunnett's method.) · Mean difference (final values): -6.68 · 95% CI -15.69 to 2.33
  • Participants Who Received Burst-SCS and Sham-SCS · Mixed Models Analysis · p = 0.9486 (P value was adjusted with Dunnett's method.) · Mean difference (final values): 1.15 · 95% CI -6.76 to 9.06
  • Participants Who Received Burst-SCS and Sham-SCS · Mixed Models Analysis · p = 0.7727 (P value was adjusted with Dunnett's method.) · Mean difference (final values): 2.62 · 95% CI -5.93 to 11.16
  • Participants Who Received Burst-SCS and Sham-SCS · Mixed Models Analysis · p = 0.2446 (P value was adjusted with Dunnett's method.) · Mean difference (final values): 3.56 · 95% CI -1.64 to 8.76
  • Participants Who Received Burst-SCS and Sham-SCS · Mixed Models Analysis · p = 0.5706 (P value was adjusted with Dunnett's method.) · Mean difference (final values): 3.12 · 95% CI -3.96 to 10.19

Adverse events

Collected over 30 days. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Burst0/25 (0%)0/25 (0%)3/25 (12%)
Kilohertz (kHz)0/24 (0%)0/24 (0%)0/24 (0%)
Sham0/24 (0%)0/24 (0%)0/24 (0%)
Tonic0/24 (0%)0/24 (0%)2/24 (8.3%)
Most frequent other events
Most frequent other events
EventBurstKilohertz (kHz)ShamTonic
Uncomfortable paresthesiaNervous system disorders1/250/240/241/24
Abnormal sensationNervous system disorders1/250/240/241/24
Pain at implantable pulse generator (IPG) siteNervous system disorders1/250/240/240/24

Baseline characteristics

Age, Continuous
Age, Continuous(years)Burst / 1kHz / Sham / 50Hz (Tonic)Burst / Sham / 1kHz / 50Hz (Tonic)1kHz / Sham / Burst / 50Hz (Tonic)1kHz / Burst / Sham / 50Hz (Tonic)Sham / Burst / 1kHz / 50Hz (Tonic)Sham / 1kHz / Burst / 50Hz (Tonic)Total
Mean56.8 ± 11.355.3 ± 11.752.8 ± 16.851.3 ± 16.857.5 ± 9.153.5 ± 5.454.4 ± 11.6
Sex: Female, Male
Sex: Female, Male(Participants)Burst / 1kHz / Sham / 50Hz (Tonic)Burst / Sham / 1kHz / 50Hz (Tonic)1kHz / Sham / Burst / 50Hz (Tonic)1kHz / Burst / Sham / 50Hz (Tonic)Sham / Burst / 1kHz / 50Hz (Tonic)Sham / 1kHz / Burst / 50Hz (Tonic)Total
Female32002310
Male12542115
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Burst / 1kHz / Sham / 50Hz (Tonic)Burst / Sham / 1kHz / 50Hz (Tonic)1kHz / Sham / Burst / 50Hz (Tonic)1kHz / Burst / Sham / 50Hz (Tonic)Sham / Burst / 1kHz / 50Hz (Tonic)Sham / 1kHz / Burst / 50Hz (Tonic)Total
Hispanic or Latino0000101
Not Hispanic or Latino44543424
Unknown or Not Reported0000000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Burst / 1kHz / Sham / 50Hz (Tonic)Burst / Sham / 1kHz / 50Hz (Tonic)1kHz / Sham / Burst / 50Hz (Tonic)1kHz / Burst / Sham / 50Hz (Tonic)Sham / Burst / 1kHz / 50Hz (Tonic)Sham / 1kHz / Burst / 50Hz (Tonic)Total
American Indian or Alaska Native0000000
Asian0000000
Native Hawaiian or Other Pacific Islander0000000
Black or African American1020104
White33343319
More than one race0100012
Unknown or Not Reported0000000
Region of Enrollment
Region of Enrollment(Participants)Burst / 1kHz / Sham / 50Hz (Tonic)Burst / Sham / 1kHz / 50Hz (Tonic)1kHz / Sham / Burst / 50Hz (Tonic)1kHz / Burst / Sham / 50Hz (Tonic)Sham / Burst / 1kHz / 50Hz (Tonic)Sham / 1kHz / Burst / 50Hz (Tonic)Total
United States44544425
08

Study locations

1 site
  • University of Michigan
    Ann Arbor, Michigan 48109, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · May 24, 2024
  • Informed consent form · Jun 11, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — There are no plans to share IPD at this time.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04732325
Lead sponsor
University of Michigan
Collaborators
National Center for Complementary and Integrative Health (NCCIH)
Responsible party
Scott Lempka (Associate Professor, University of Michigan) — Principal investigator
First posted
Feb 1, 2021
Start date
Sep 11, 2021
Primary completion
Jun 18, 2024
Completion
Jun 18, 2024
Results posted
Mar 27, 2026
Last update
Mar 27, 2026

Study contacts

Scott Lempka, PhD
principal investigator · University of Michigan

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion